CAS 1402727-29-0

PE859

CAS : 1402727-29-0

Formule : C₂₈H₂₄N₄O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 448.5158

Ref: IN-DA01EOOF

6-((E)-2-(3-((E)-2-Methoxy-4-(Pyridin-2-Ylmethoxy)Styryl)-1H-Pyrazol-5-Yl)Vinyl)-1H-Indole

CAS : 1402727-29-0

6-((E)-2-(3-((E)-2-Methoxy-4-(Pyridin-2-Ylmethoxy)Styryl)-1H-Pyrazol-5-Yl)Vinyl)-1H-Indole

Degré de pureté : 99%

Masse moléculaire : 448.52g/mol

Ref: 54-OR1024174

PE859

CAS : 1402727-29-0

PE859

Degré de pureté : ≥98%

Masse moléculaire : 448.52g/mol

Ref: 54-BUP09397

PE859

CAS : 1402727-29-0

PE859 is a potent inhibitor of both tau and Aβ aggregation.

Formule : C₂₈H₂₄N₄O₂

Degré de pureté : 98.8% - 99.09%

Couleur et forme : Solid

Masse moléculaire : 448.52

Ref: TM-T4077

PE859

CAS : 1402727-29-0

PE859 is a small molecule that inhibits the activity of the enzyme beta-site amyloid precursor protein cleaving enzyme 1 (BACE1). It has been shown to reduce plaque formation and ameliorate symptoms in an Alzheimer's disease mouse model. PE859 also has antiviral properties, which have been demonstrated using a cell culture system and microscopy studies. The mechanism of action for its antiviral properties is not known, but may be related to its ability to inhibit BACE1 activity.

Formule : C₂₈H₂₄N₄O₂

Degré de pureté : Min. 95%

Masse moléculaire : 448.52 g/mol

Ref: 3D-CGC72729